Search by Drug Name or NDC
NDC 62584-0814-01 Oxazepam 30 mg/1 Details
Oxazepam 30 mg/1
Oxazepam is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is OXAZEPAM.
MedlinePlus Drug Summary
Oxazepam is used to relieve anxiety, including anxiety caused by alcohol withdrawal (symptoms that may develop in people who stop drinking alcohol after drinking large amounts for a long time). Oxazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow for relaxation.
Related Packages: 62584-0814-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Oxazepam
Product Information
| NDC | 62584-0814 |
|---|---|
| Product ID | 62584-814_0b92fa4e-ace4-7e15-e063-6294a90ab0e5 |
| Associated GPIs | 57100070000115 |
| GCN Sequence Number | 003771 |
| GCN Sequence Number Description | oxazepam CAPSULE 30 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14232 |
| HICL Sequence Number | 001616 |
| HICL Sequence Number Description | OXAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | Oxazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Oxazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, GELATIN COATED |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | OXAZEPAM |
| Labeler Name | American Health Packaging |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA072253 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62584-0814-01 (62584081401)
| NDC Package Code | 62584-814-01 |
|---|---|
| Billing NDC | 62584081401 |
| Package | 100 BLISTER PACK in 1 CARTON (62584-814-01) / 1 CAPSULE, GELATIN COATED in 1 BLISTER PACK (62584-814-11) |
| Marketing Start Date | 2007-12-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.341 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | OXAZEPAM 30 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis